143 related articles for article (PubMed ID: 37695066)
1. Identification and characterization of shark VNARs targeting the
Gao Y; Wang R; Liu L; Feng S; Xi X; Yu W; Gu Y; Wang Y
Artif Cells Nanomed Biotechnol; 2023 Sep; 51(1):509-519. PubMed ID: 37695066
[No Abstract] [Full Text] [Related]
2. Exploring shark VNAR antibody against infectious diseases using phage display technology.
Lim HT; Kok BH; Leow CY; Leow CH
Fish Shellfish Immunol; 2023 Sep; 140():108986. PubMed ID: 37541634
[TBL] [Abstract][Full Text] [Related]
3. Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (
Zhao L; Chen M; Wang X; Kang S; Xue W; Li Z
Mar Drugs; 2022 Apr; 20(5):. PubMed ID: 35621957
[TBL] [Abstract][Full Text] [Related]
4. Selection, identification and crystal structure of shark-derived single-domain antibodies against a green fluorescent protein.
Chen YL; Xie XX; Zheng P; Zhu C; Ma H; Khalid Z; Xie YJ; Dang YZ; Ye Y; Sheng N; Zhong N; Lei WH; Zhang C; Zhang LJ; Jin T; Cao MJ
Int J Biol Macromol; 2023 Aug; 247():125852. PubMed ID: 37460076
[TBL] [Abstract][Full Text] [Related]
5. Construction and next-generation sequencing analysis of a large phage-displayed V
Feng M; Bian H; Wu X; Fu T; Fu Y; Hong J; Fleming BD; Flajnik MF; Ho M
Antib Ther; 2019 Jan; 2(1):1-11. PubMed ID: 30627698
[No Abstract] [Full Text] [Related]
6. Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks (
Jiang X; Sun S; Li Z; Chen M
Mar Drugs; 2023 Apr; 21(4):. PubMed ID: 37103376
[TBL] [Abstract][Full Text] [Related]
7. Recombinant HpaA purified from Escherichia coli has biological properties similar to those of native Helicobacter pylori HpaA.
Lundstrom A; Bolin I; Bystrom M; Nystrom S
APMIS; 2003 Mar; 111(3):389-97. PubMed ID: 12752218
[TBL] [Abstract][Full Text] [Related]
8. Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein.
Chen YL; Lin JJ; Ma H; Zhong N; Xie XX; Yang Y; Zheng P; Zhang LJ; Jin T; Cao MJ
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142819
[TBL] [Abstract][Full Text] [Related]
9. [Screening and characterization of nucleic acid aptamers specifically binding to adhesin HpaA from Helicobacter pylori].
Hua Y; Chen L; Li S; Zhou F; Tang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jun; 35(6):533-539. PubMed ID: 31292058
[TBL] [Abstract][Full Text] [Related]
10. Construction of hpaA gene from a clinical isolate of Helicobacter pylori and identification of fusion protein.
Mao YF; Yan J; Li LW; Li SP
World J Gastroenterol; 2003 Jul; 9(7):1529-36. PubMed ID: 12854157
[TBL] [Abstract][Full Text] [Related]
11. [Cloning, expression and identification of hpaA gene from a clinical isolate of Helicobacter pylori].
Mao YF; Yan J; Li LW
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Feb; 32(1):9-12. PubMed ID: 12640701
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography.
Ubah OC; Lake EW; Gunaratne GS; Gallant JP; Fernie M; Robertson AJ; Marchant JS; Bold TD; Langlois RA; Matchett WE; Thiede JM; Shi K; Yin L; Moeller NH; Banerjee S; Ferguson L; Kovaleva M; Porter AJ; Aihara H; LeBeau AM; Barelle CJ
Nat Commun; 2021 Dec; 12(1):7325. PubMed ID: 34916516
[TBL] [Abstract][Full Text] [Related]
13. Shark VNAR phage display libraries: An alternative source for therapeutic and diagnostic recombinant antibody fragments.
Manoutcharian K; Gevorkian G
Fish Shellfish Immunol; 2023 Jul; 138():108808. PubMed ID: 37169114
[TBL] [Abstract][Full Text] [Related]
14. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
[TBL] [Abstract][Full Text] [Related]
15. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
16. Ancient species offers contemporary therapeutics: an update on shark V
English H; Hong J; Ho M
Antib Ther; 2020 Jan; 3(1):1-9. PubMed ID: 32118195
[TBL] [Abstract][Full Text] [Related]
17. Generation of VNAR Libraries from Immunized Sharks and Selection of Target-Specific Clones.
Dooley H
Methods Mol Biol; 2022; 2421():57-72. PubMed ID: 34870811
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of malaria PfHRP2 specific V
Leow CH; Fischer K; Leow CY; Braet K; Cheng Q; McCarthy J
Malar J; 2018 Oct; 17(1):383. PubMed ID: 30355309
[TBL] [Abstract][Full Text] [Related]
19. Overview, Generation, and Significance of Variable New Antigen Receptors (VNARs) as a Platform for Drug and Diagnostic Development.
Pandey SS; Kovaleva M; Barelle CJ; Ubah OC
Methods Mol Biol; 2022; 2446():19-33. PubMed ID: 35157267
[TBL] [Abstract][Full Text] [Related]
20. Unleashing the power of shark variable single domains (VNARs): broadly neutralizing tools for combating SARS-CoV-2.
Cabanillas-Bernal O; Valdovinos-Navarro BJ; Cervantes-Luevano KE; Sanchez-Campos N; Licea-Navarro AF
Front Immunol; 2023; 14():1257042. PubMed ID: 37753081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
